50
Participants
Start Date
May 31, 2007
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Bortezomib
"Bortezomib will be administered at a dose of 1.6 mg/m2 IV push. Treatment will be administered once a week for four weeks followed by one week off. This 5 week period is considered a treatment cycle.~Dexamethasone will also be administered at a dose of 40mg on the day of and day after each dose of bortezomib, with a dose reduction to 20mg on the same schedule if the patient cannot tolerate the higher dose of dexamethasone."
Pittsburgh VA Medical Center, Pittsburgh
Atlanta VA Medical Center, Atlanta
Tampa VA Medical Center, Tampa
Kansas City VA Medical Center, Kansas City
Little Rock VA Medical Center, Little Rock
Michael E. DeBakey VA Medical Center, Houston
Eastern Colorado Health Care System, Denver
West Los Angeles VA Medical Center, Los Angeles
San Francisco VA Medical Center, San Francisco
West Haven VA Medical Center, West Haven
VA Boston Healthcare System, Jamaica Plain
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
Boston VA Research Institute, Inc.
OTHER